Dr. Peter Infante

EPA Bows to Chemical Industry in Delay of Glyphosate Cancer Review

Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram

By Carey Gillam This might have been a tough week for Monsanto Co. The Environmental Protection Agency was slated to hold four days of public meetings focused on essentially one question: Is glyphosate, the world’s most widely used herbicide and the lynchpin to Monsanto’s fortunes, as safe as Monsanto has spent 40 years telling us EPA Bows to Chemical Industry in Delay of Glyphosate Cancer Review

Serious scrutiny needed as EPA seeks input on cancer ties to Monsanto herbicide

Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram

By Carey Gillam The glyphosate geeks are gathering in Washington this week. After a two-month delay, the Environmental Protection Agency (EPA) is holding four days of meetings aimed at examining the evidence that does or does not tie the world’s most widely used herbicide — glyphosate — to cancer. Scientists, activists and agricultural industry leaders Serious scrutiny needed as EPA seeks input on cancer ties to Monsanto herbicide